Europe - Point-of-Care Testing (POCT) Market By Type, Application, Geography - Forecast And Analysis 2023-2027

Published: Jul 2023 Pages: 162 SKU: IRTNTR75993

Europe Point-of-Care Testing (POCT) Market Analysis Report 2023-2027:

The Europe Point-of-Care Testing (POCT) Market size is estimated to grow by USD 5,750.84 million at a CAGR of 7.75% between 2022 and 2027. 

Due to the development of genome technology, whole genome technology, and companion diagnostics, there is an increased focus on personalized medicine. This will increase the demand for diagnostic devices that can diagnose diseases and allow personalized treatment according to individual diagnostic responses. Additionally, genetic and acquired factors play an important role in the development of VTE. Current management of VTE is primarily determined by the presence or absence of significant precipitating and modifiable factors. Moreover, the availability of POCT devices has greatly advanced current research on personalized medicine, especially in the treatment of blood disorders. With this device, a large amount of patient measurement data can be measured. Hence, an increasing focus on personalized medicine is expected to drive the growth of the Europe POCT market during the forecast period. 

Technavio has segmented the market into Type and Application segments. 

  • The type segment includes OTC testing and prescription-based testing
  • The application segment includes blood glucose testing, infectious diseases testing, cardiac markers testing, pregnancy and fertility testing, and others

It also includes an in-depth analysis of drivers, trends, and challenges. 

What will be the size of the Europe POCT Market During the Forecast Period?

To learn more about this report, Request Free Sample

Europe POCT Market Segmentation by Type, Application and Geography Analysis

Type Analysis 

OTC Testing 

The market share growth by the OTC testing segment will be significant during the forecast period. The POCT OTC test is a test product that can be purchased without a doctor's prescription. This kind of trial product is easily available and comes at a cheaper price compared to prescription-based POCT products.

Get a glance at the market contribution of various segments View a PDF Sample

The OTC testing segment was valued at USD 5,801.10 million in 2017. OTC POCT provides rapid, accurate results to help diagnose and treat acute or chronic diseases such as cardiovascular disease, diabetes, and influenza. OTC POCT includes point-of-treatment screening and testing, with results available in minutes. Therefore, the factors mentioned above fuel the growth of OTC testing in the Europe point-of-care testing (POCT) market during the forecast period.

Application Analysis

Blood glucose testing

Patients with symptoms of acute diabetes want to know exactly how serious their condition is. In such cases, a POCT blood glucose measurement can help. This POCT blood glucose test measures whole blood levels at the patient's bedside and converts the results to a standard clinical measurement with the plasma glucose concentration (PGC). The increasing prevalence of diabetes in the European population and the growing adoption of non-invasive rapid blood glucose testing methods are expected to drive the growth of blood glucose testing in the Europe point-of-care testing market during the forecast period. 

Infectious diseases testing

The infectious disease testing segment is driven by the emergence of infectious diseases such as human immunodeficiency virus (HIV), human papillomavirus (HPV), influenza, coronavirus disease (COVID-19), and respiratory disease. Due to the high number of infectious diseases, the need for POC diagnostic tests is increasing.  For instance, Abbott Laboratories offers the BinaxNOW Malaria Test, an in vitro immunochromatographic test for the qualitative detection of circulating Plasmodium antigens in human blood. It is useful for rapid diagnosis of human malaria infections and differential diagnosis between Plasmodium falciparum infections and other less virulent malaria infections. Hence. this is anticipated to drive the growth of the infectious disease testing segment of the Europe Point-of-Care testing market during the forecast period. 

Buy Now Full Report and Discover More

Key Europe POCT Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Abbott Laboratories: The company offers point-of-care testing devices such as PIMA analyzer, Afinion ACR, and Binaxnow COVID-19 Ag card.

  • A. Menarini Industrie Farmaceutiche Riunite Srl
  • ACON Laboratories Inc.
  • Becton Dickinson and Co.
  • bioMerieux SA
  • Chembio Diagnostics Inc.
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • Fluxergy Inc.
  • Johnson and Johnson Services Inc.
  • LifeScan IP Holdings LLC
  • Nova Biomedical Corp
  • OraSure Technologies Inc.
  • PHC Holdings Corp.
  • Sd Biosensor Inc.
  • Siemens AG
  • Sinocare Inc.
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Plc

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Europe POCT Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Europe POCT Market Drivers

The growing adoption of automated diagnostic devices in the healthcare industry is one of the key factors for the growth of the Europe POCT market. Fully automated laboratory solutions help to save costs and deliver effective results to end users such as hospitals and clinics, clinical diagnostic laboratories, and home care facilities. Automated solutions also save labor costs by replacing manual-intensive tasks, allowing researchers to spend more time analyzing and interpreting data. In addition, the automated solution eliminates human error, increasing overall lab productivity.

Moreover, automated diagnostic devices also offer different approaches, such as dynamic range selection for various tests (such as lipid panels and biochemical analysis) to simplify workflow. The efficiency and effectiveness of these devices are expected to increase their acceptance during the forecast period, which is likely to drive the growth of the focused market during the forecast period.

Significant Europe POCT Market Trends

A shift from conventional testing methods to rapid diagnostic tests is the primary trend in the Europe POCT market. Rapid diagnosis means getting results from a blood sample in less time than traditional methods such as clinical settings diagnostic tests. This process is performed through a rapid diagnostic test (RDT). RDT is a medical test that is easier and faster to perform. They are suitable for primary or emergency medical screening and can be performed in resource-constrained medical facilities. Several POC tests that were previously confined to laboratories are now being performed in primary care. This POC test provides results within two hours. Therefore, RDTs are becoming very popular. 

Moreover, there is a growing need for tests that can detect malaria in asymptomatic populations with low infection rates. The development of a rapid diagnostic test for diagnosing malaria has proven to be an ideal solution for laboratories and treating physicians. Prompt availability of blood test results from patients with suspected acute malaria is critical to determining appropriate treatment strategies. Hence, as POC diagnostics equipment continues to support rapid diagnostics, the demand for such equipment is set to grow further in the coming years. That will fuel the growth of the POCT market in Europe during the forecast period.

Major Europe POCT Market Challenges

Stringent government regulations in different countries affect the growth of the Europe POCT market. ??Commercialization of medical testing products such as POCT is a difficult process as some products are classified as medical devices because they are used for diagnostic purposes thus these regulations affect the point of care diagnostics market. The European Union (EU) regulates medical devices, including medical devices used to perform genetic tests (including DNA microarray devices), under Medical Device Regulations (EU) 2017/745 and 2017/746. Therefore, POC diagnostic products cannot be brought to market without successfully completing expensive, time-consuming, and uncertain clinical trials.

Additionally, changes in EU regulatory policies during product development can delay the launch of new products. Besides, the costs of clinical trials and product launches fluctuate with various regulatory policies, leading to raised market players spending. Hence, stringent government regulations in various European countries are impacting the development and demand for equipment such as POC diagnostics, which will impede the growth of the European POCT market during the forecast period.

Buy Now Full Report and Discover More

Key Europe POCT Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Europe POCT Market Customer Landscape

Segment Overview

The Europe POCT market report forecasts market growth by revenue and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Type Outlook (USD Million, 2017 - 2027)
    • OTC testing
    • Prescription-based testing
  • Application Outlook (USD Million, 2017 - 2027)
    • Blood glucose testing
    • Infectious diseases testing
    • Cardiac markers testing
    • Pregnancy and fertility testing
    • Others

Europe POCT Market Scope

Report Coverage

Details

Page number

162

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 7.75%

Market growth 2023-2027

USD 5,750.84 million

Market structure

Fragmented

Competitive landscape

 Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks

Key companies profiled

A. Menarini Industrie Farmaceutiche Riunite Srl, Abbott Laboratories, ACON Laboratories Inc., Becton Dickinson and Co., bioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Fluxergy Inc., Johnson and Johnson Services Inc., LifeScan IP Holdings LLC, Nova Biomedical Corp., OraSure Technologies Inc., PHC Holdings Corp., Sd Biosensor Inc., Siemens AG, Sinocare Inc., Sysmex Corp., Thermo Fisher Scientific Inc., and Trinity Biotech Plc

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. 

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Europe POCT Market in Regional Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the Europe POCTmarket between 2023 and 2027
  • Precise estimation of the Europe POCT market size and its contribution of the market in focus to the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies' position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across Europe
  • Thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of  Europe POCTmarket companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Country Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Regional - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Europe: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Regional - Market size and forecast 2022-2027 ($ million)

    4 Historic Market Size

    • 4.1 POCT market in Europe 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on poct market in Europe 2017 - 2021 ($ million)
    • 4.2 Type Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ million)
    • 4.3 Application Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Application Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 22: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 23: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 24: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 25: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 26: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 27: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 28: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 29: Chart on Type - Market share 2022-2027 (%)
      • Exhibit 30: Data Table on Type - Market share 2022-2027 (%)
    • 6.2 Comparison by Type
      • Exhibit 31: Chart on Comparison by Type
      • Exhibit 32: Data Table on Comparison by Type
    • 6.3 OTC testing - Market size and forecast 2022-2027
      • Exhibit 33: Chart on OTC testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 34: Data Table on OTC testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Chart on OTC testing - Year-over-year growth 2022-2027 (%)
      • Exhibit 36: Data Table on OTC testing - Year-over-year growth 2022-2027 (%)
    • 6.4 Prescription-based testing - Market size and forecast 2022-2027
      • Exhibit 37: Chart on Prescription-based testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 38: Data Table on Prescription-based testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Chart on Prescription-based testing - Year-over-year growth 2022-2027 (%)
      • Exhibit 40: Data Table on Prescription-based testing - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Type
      • Exhibit 41: Market opportunity by Type ($ million)
      • Exhibit 42: Data Table on Market opportunity by Type ($ million)

    7 Market Segmentation by Application

    • 7.1 Market segments
      • Exhibit 43: Chart on Application - Market share 2022-2027 (%)
      • Exhibit 44: Data Table on Application - Market share 2022-2027 (%)
    • 7.2 Comparison by Application
      • Exhibit 45: Chart on Comparison by Application
      • Exhibit 46: Data Table on Comparison by Application
    • 7.3 Blood glucose testing - Market size and forecast 2022-2027
      • Exhibit 47: Chart on Blood glucose testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Data Table on Blood glucose testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 49: Chart on Blood glucose testing - Year-over-year growth 2022-2027 (%)
      • Exhibit 50: Data Table on Blood glucose testing - Year-over-year growth 2022-2027 (%)
    • 7.4 Infectious diseases testing - Market size and forecast 2022-2027
      • Exhibit 51: Chart on Infectious diseases testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 52: Data Table on Infectious diseases testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Chart on Infectious diseases testing - Year-over-year growth 2022-2027 (%)
      • Exhibit 54: Data Table on Infectious diseases testing - Year-over-year growth 2022-2027 (%)
    • 7.5 Cardiac markers testing - Market size and forecast 2022-2027
      • Exhibit 55: Chart on Cardiac markers testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 56: Data Table on Cardiac markers testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Chart on Cardiac markers testing - Year-over-year growth 2022-2027 (%)
      • Exhibit 58: Data Table on Cardiac markers testing - Year-over-year growth 2022-2027 (%)
    • 7.6 Pregnancy and fertility testing - Market size and forecast 2022-2027
      • Exhibit 59: Chart on Pregnancy and fertility testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 60: Data Table on Pregnancy and fertility testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Chart on Pregnancy and fertility testing - Year-over-year growth 2022-2027 (%)
      • Exhibit 62: Data Table on Pregnancy and fertility testing - Year-over-year growth 2022-2027 (%)
    • 7.7 Others - Market size and forecast 2022-2027
      • Exhibit 63: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 64: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 65: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 66: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 7.8 Market opportunity by Application
      • Exhibit 67: Market opportunity by Application ($ million)
      • Exhibit 68: Data Table on Market opportunity by Application ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 70: Chart on Market share by geography - 2022-2027 (%)
      • Exhibit 71: Data Table on Market share by geography - 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 72: Chart on Geographic comparison
      • Exhibit 73: Data Table on Geographic comparison
    • 9.3 Germany - Market size and forecast 2022-2027
      • Exhibit 74: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 75: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 77: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.4 France - Market size and forecast 2022-2027
      • Exhibit 78: Chart on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 79: Data Table on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Chart on France - Year-over-year growth 2022-2027 (%)
      • Exhibit 81: Data Table on France - Year-over-year growth 2022-2027 (%)
    • 9.5 Italy - Market size and forecast 2022-2027
      • Exhibit 82: Chart on Italy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 83: Data Table on Italy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Chart on Italy - Year-over-year growth 2022-2027 (%)
      • Exhibit 85: Data Table on Italy - Year-over-year growth 2022-2027 (%)
    • 9.6 UK - Market size and forecast 2022-2027
      • Exhibit 86: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 87: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 89: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.7 Rest of Europe - Market size and forecast 2022-2027
      • Exhibit 90: Chart on Rest of Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 91: Data Table on Rest of Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Chart on Rest of Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 93: Data Table on Rest of Europe - Year-over-year growth 2022-2027 (%)
    • 9.8 Market opportunity by geography
      • Exhibit 94: Market opportunity by geography ($ million)
      • Exhibit 95: Data Table on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 96: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 97: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 98: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 99: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 100: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 101: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 102: Abbott Laboratories - Overview
              • Exhibit 103: Abbott Laboratories - Business segments
              • Exhibit 104: Abbott Laboratories - Key news
              • Exhibit 105: Abbott Laboratories - Key offerings
              • Exhibit 106: Abbott Laboratories - Segment focus
            • 12.4 Becton Dickinson and Co.
              • Exhibit 107: Becton Dickinson and Co. - Overview
              • Exhibit 108: Becton Dickinson and Co. - Business segments
              • Exhibit 109: Becton Dickinson and Co. - Key news
              • Exhibit 110: Becton Dickinson and Co. - Key offerings
              • Exhibit 111: Becton Dickinson and Co. - Segment focus
            • 12.5 bioMerieux SA
              • Exhibit 112: bioMerieux SA - Overview
              • Exhibit 113: bioMerieux SA - Product / Service
              • Exhibit 114: bioMerieux SA - Key offerings
            • 12.6 Danaher Corp.
              • Exhibit 115: Danaher Corp. - Overview
              • Exhibit 116: Danaher Corp. - Business segments
              • Exhibit 117: Danaher Corp. - Key news
              • Exhibit 118: Danaher Corp. - Key offerings
              • Exhibit 119: Danaher Corp. - Segment focus
            • 12.7 F. Hoffmann La Roche Ltd.
              • Exhibit 120: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 121: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 122: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 123: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 124: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.8 Fluxergy Inc.
              • Exhibit 125: Fluxergy Inc. - Overview
              • Exhibit 126: Fluxergy Inc. - Product / Service
              • Exhibit 127: Fluxergy Inc. - Key offerings
            • 12.9 Johnson and Johnson Services Inc.
              • Exhibit 128: Johnson and Johnson Services Inc. - Overview
              • Exhibit 129: Johnson and Johnson Services Inc. - Business segments
              • Exhibit 130: Johnson and Johnson Services Inc. - Key news
              • Exhibit 131: Johnson and Johnson Services Inc. - Key offerings
              • Exhibit 132: Johnson and Johnson Services Inc. - Segment focus
            • 12.10 LifeScan IP Holdings LLC
              • Exhibit 133: LifeScan IP Holdings LLC - Overview
              • Exhibit 134: LifeScan IP Holdings LLC - Product / Service
              • Exhibit 135: LifeScan IP Holdings LLC - Key offerings
            • 12.11 Nova Biomedical Corp.
              • Exhibit 136: Nova Biomedical Corp. - Overview
              • Exhibit 137: Nova Biomedical Corp. - Product / Service
              • Exhibit 138: Nova Biomedical Corp. - Key offerings
            • 12.12 PHC Holdings Corp.
              • Exhibit 139: PHC Holdings Corp. - Overview
              • Exhibit 140: PHC Holdings Corp. - Business segments
              • Exhibit 141: PHC Holdings Corp. - Key offerings
              • Exhibit 142: PHC Holdings Corp. - Segment focus
            • 12.13 Siemens AG
              • Exhibit 143: Siemens AG - Overview
              • Exhibit 144: Siemens AG - Business segments
              • Exhibit 145: Siemens AG - Key news
              • Exhibit 146: Siemens AG - Key offerings
              • Exhibit 147: Siemens AG - Segment focus
            • 12.14 Sinocare Inc.
              • Exhibit 148: Sinocare Inc. - Overview
              • Exhibit 149: Sinocare Inc. - Product / Service
              • Exhibit 150: Sinocare Inc. - Key news
              • Exhibit 151: Sinocare Inc. - Key offerings
            • 12.15 Sysmex Corp.
              • Exhibit 152: Sysmex Corp. - Overview
              • Exhibit 153: Sysmex Corp. - Business segments
              • Exhibit 154: Sysmex Corp. - Key offerings
              • Exhibit 155: Sysmex Corp. - Segment focus
            • 12.16 Thermo Fisher Scientific Inc.
              • Exhibit 156: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 157: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 158: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 159: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 160: Thermo Fisher Scientific Inc. - Segment focus
            • 12.17 Trinity Biotech Plc
              • Exhibit 161: Trinity Biotech Plc - Overview
              • Exhibit 162: Trinity Biotech Plc - Product / Service
              • Exhibit 163: Trinity Biotech Plc - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 164: Inclusions checklist
                • Exhibit 165: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 166: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 167: Research methodology
                • Exhibit 168: Validation techniques employed for market sizing
                • Exhibit 169: Information sources
              • 13.5 List of abbreviations
                • Exhibit 170: List of abbreviations

                Research Framework

                Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                INFORMATION SOURCES

                Primary sources

                • Manufacturers and suppliers
                • Channel partners
                • Industry experts
                • Strategic decision makers

                Secondary sources

                • Industry journals and periodicals
                • Government data
                • Financial reports of key industry players
                • Historical data
                • Press releases

                DATA ANALYSIS

                Data Synthesis

                • Collation of data
                • Estimation of key figures
                • Analysis of derived insights

                Data Validation

                • Triangulation with data models
                • Reference against proprietary databases
                • Corroboration with industry experts

                REPORT WRITING

                Qualitative

                • Market drivers
                • Market challenges
                • Market trends
                • Five forces analysis

                Quantitative

                • Market size and forecast
                • Market segmentation
                • Geographical insights
                • Competitive landscape

                PURCHASE FULL REPORT OF

                poct market

                QUICK BUY

                Key Questions Answered

                • What are the key global market and the regional market share?
                • What are the revenue-generating key market segments?
                • What are the key factors driving and challenging this market’s growth?
                • Who are the key market vendors and their growth strategies?
                • What are the latest trends influencing the growth of this market?
                • What are the variables influencing the market growth in the primary regions?
                • What are the factors influencing the growth of the parent market?

                Why should you prefer Technavio's market insights report?

                • Off-the-shelf research reports
                • Reports can be tailored to meet the customer's needs
                • Trusted by more than 100 fortune 500 organizations
                • Information about the market's key drivers, trends, and challenges
                • Parent market analysis
                • Every week, 50,000 people visit our subscription platform
                • Detailed vendors report with competitive landscape
                • Covid-19 impact and recovery analysis
                • Data on revenue-generating market segments
                • Details on the market shares of various regions
                • Five-force market analysis